1 / 8

Narcolepsy Market to Portray US$ 4,537.9 million by 2027

Narcolepsy is a rare long-term brain disorder characterized by excessive sleepiness, sleep paralysis, hallucinations, and episodes of cataplexy among certain patients.<br><br>Read More:- https://www.theinsightpartners.com/reports/narcolepsy-market

Karan45
Télécharger la présentation

Narcolepsy Market to Portray US$ 4,537.9 million by 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Narcolepsy Market Global Analysis and Forecast to 2027 Published Date : Feb 2019 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Narcolepsy Market to 2027- Global Analysis and Forecasts by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy), Product [Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants], and Distribution Channel (Hospital Pharmacies and Retail Pharmacies)

  3. Email:sales@theinsightpartners.com Narcolepsy Market Value CAGR of 9.5% (2019 to 2027)

  4. Email:sales@theinsightpartners.com Narcolepsy Market Overview • The narcolepsy market size is estimated to reach US$ 4,537.9 million by 2027 from US$ 2,026.8 million in 2018; it is estimated to grow at a CAGR of 9.5% during 2019-2027. • Narcolepsy is a rare long-term brain disorder characterized by excessive sleepiness, sleep paralysis, hallucinations, and episodes of cataplexy among certain patients.

  5. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy) • Product [Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants] • Distribution Channel (Hospital Pharmacies and Retail Pharmacies)

  6. Email:sales@theinsightpartners.com Company Profiles • Bioprojet • Teva Pharmaceutical Industries Ltd. • Jazz Pharmaceuticals, Inc. • Graymark Healthcare, Inc. • Arena Pharmaceuticals, Inc. • Shire (Acquired by Takeda) • Ligand Pharmaceuticals, Inc. • Novartis AG • Mylan N.V. • Shionogi Inc. Download Sample Here

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related